Discontinuation report SUPREFACT DEPOT 3 MONTHS
| Report ID | 228166 |
| Drug Identification Number | 02240749 |
| Brand name | SUPREFACT DEPOT 3 MONTHS |
| Common or Proper name | buserelin acetate implant |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | BUSERELIN |
| Strength(s) | 9.45MG |
| Dosage form(s) | IMPLANT |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 applicator |
| ATC code | L02AE |
| ATC description | HORMONES AND RELATED AGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-05-16 |
| Remaining supply date | 2024-05-16 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-05-17 | English | Compare |
| v2 | 2024-05-16 | French | Compare |
| v1 | 2024-05-16 | English | Compare |
Showing 1 to 3 of 3